Manufacturing news briefs — stories you might have missed
Orthocell’s strong sales growth Tissue regeneration technology developer Orthocell has announced sales growth across its product portfolio, with total revenue for FY24 of $6.72 million – up 30.40 percent from FY23. Record revenue of $1.84m was achieved for the June 24 Quarter, up 14.41 percent. With Striate+ currently sold in the US, Europe/UK, Australia and…